The global antibody therapy market is set to grow from USD 235 billion in 2023 to USD 824.0 billion by 2033, at a CAGR of ...

A news feature on the research paper "Next-generation cell-penetrating antibodies for tumor targeting and RAD51 inhibition" by Rackear et al. was published in Oncotarget's Volume 15 on November 22, ...

ImmunoPrecise Antibodies (IPA – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst ...

Nona Biosciences, a global biotechnology company providing a total solution from 'Idea to IND' (I to ITM), ranging from ...

Kumamoto University researchers have identified a powerful antibody that can neutralize a wide range of SARS-CoV-2 variants, ...

Researchers at Kumamoto University have discovered a monoclonal antibody capable of neutralizing a wide range of SARS-CoV-2 ...

Dapu Biotechnology (DPBIO), an industry leader in droplet microfluidic technology, and Leveragen, Inc., a Boston-based biotech developing advanced gen ...

Business combination closed November 13, 2024Raised $10 million of gross proceeds in connection with the business combinationAgreements are in ...

Monoclonal antibodies (mAb) have emerged as a promising tool in advancing personalized medicine."BUFFALO, NY – December 11, 2024 – A news feature on ...

A news feature on the research paper “Next-generation cell-penetrating antibodies for tumor targeting and RAD51 inhibition” ...

Nona Biosciences has partnered with Kodiak Sciences to develop multi-target antibodies for ophthalmic diseases. Utilizing ...